Kevin Young
2009
In 2009, Kevin Young earned a total compensation of $4.6M as Executive Vice President, Commercial Operations at Gilead Sciences, a 12% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $504,450 |
|---|---|
| Option Awards | $1,555,702 |
| Salary | $596,672 |
| Stock Awards | $1,906,322 |
| Other | $5,000 |
| Total | $4,568,146 |
Young received $1.9M in stock awards, accounting for 42% of the total pay in 2009.
Young also received $504.5K in non-equity incentive plan, $1.6M in option awards, $596.7K in salary and $5K in other compensation.
Rankings
In 2009, Kevin Young's compensation ranked 837th out of 9,885 executives tracked by ExecPay. In other words, Young earned more than 91.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 837 out of 9,885 | 92nd |
Division Manufacturing | 291 out of 3,690 | 92nd |
Major group Chemicals And Allied Products | 74 out of 866 | 92nd |
Industry group Drugs | 49 out of 638 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 4 out of 133 | 97th |
Source: SEC filing on March 20, 2012.
Young's colleagues
We found five more compensation records of executives who worked with Kevin Young at Gilead Sciences in 2009.
2009
John Martin
Gilead Sciences
Chief Executive Officer
2009
John Milligan
Gilead Sciences
Chief Operating Officer
2009
Norbert Bischofberger
Gilead Sciences
Chief Scientific Officer
2009
Gregg Alton
Gilead Sciences
Executive Vice President, Corporate and Medical Affairs
2009
Robin Washington
Gilead Sciences